ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Mycobacterium Abscessus Infection in Solid Organ Transplant Recipients Over Five Years. A Single Center Experience

Y. Ebisu1, Y. Natori2, G. Rosello3, J. Simkins2, J. Camargo2, S. Anjan2, M. Morris2, O. V. Martinez4, L. Abbo2

1Infectious Disease, Kameda Medical Center, Kamogawa, Japan, 2Transplant Infectious Disease, Jackson Memorial Hospital/Miami Transplant Institute, Miami, FL, 3Infectious Disease, Jackson Memorial Hospital/Miami Transplant Institute, Miami, FL, 4Jackson Memorial Hospital/Miami Transplant Institute, Miami, FL

Meeting: 2020 American Transplant Congress

Abstract number: 602

Keywords: Infection

Session Information

Session Name: Infection Potpourri

Session Type: Oral Abstract Session

Date: Saturday, May 30, 2020

Session Time: 3:15pm-4:45pm

 Presentation Time: 4:27pm-4:39pm

Location: Virtual

*Purpose: Mycobacterium abscessus is increasingly recognised as a human pathogen causing life-threatening infections in immunocompetent patients. Data about clinical outcomes of M. abscessus infections in solid organ transplant (SOT) recipients is limited.

*Methods: We conducted a retrospective cohort study in large academic transplant center in Miami, Florida. The cohort included a retrospective electronic medical record review of all SOT recipients with a positive culture for M.abscessus between January 1st, 2013 and September 30th, 2018. Treatment failure was characterized either by persistent positive culture for M.abscessus and/or lack of radiographic improvement within 12 weeks of treatment initiation, or death attributed to M.abscessus infection.

*Results: A total of 20 patients were included (50% female). 1(5.0%), 2(10.0%), 12(60.0%), 1(5.0%), and 4(20.0%) were kidney, liver, lung, heart, intestine and multivisceral recipients respectively. The median time to infection from SOT was 100 days (IQR: 30-431). 7 patients were not treated as their cultures represented colonization or contamination. 2 of these patients died (unrelated to infection) and 5 had no evidence of M.abscessus infection after one year of follow-up. 13 (65.0%) patients (Kidney 1, Heart 1, lung 7, Liver 1, Intestine 1, and multivisceral 2) patients were treated with combination of antibiotics with a median duration of 160 (IQR: 20-523) days; 4 (20.0%) patients had treatment failure and 3 (15.0%) had unrelated deaths within one year after diagnosis. 7/12(58.3%) lung transplant recipients were diagnosed as active infection and treated with a median duration of 184 (IQR: 20-186) antibiotic days. In our study, M.abscessus massilience (7, 58.3%) was the most common isolate, followed by M.bolletii(4, 33.3%).

*Conclusions: M.abscessus is infrequent in SOT with serious morbidity and potential mortality; is difficult to treat with potential adverse events from combined prolonged antibiotics. Our cohort demonstrated favourable outcomes but we did see a 20% treatment failure. Most organisms were identified in lung recipients yet not all were consider infected and as such were not treated, these patients had no evidence of infection within the study period. Transplant providers should carefully weigh the clinical characteristics in addition to microbiology cultures as M.abscessus could represented colonization with very low or no risk to develop infection and may not require antibiotic treatment in selected patients including lung recipients.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Ebisu Y, Natori Y, Rosello G, Simkins J, Camargo J, Anjan S, Morris M, Martinez OV, Abbo L. Mycobacterium Abscessus Infection in Solid Organ Transplant Recipients Over Five Years. A Single Center Experience [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/mycobacterium-abscessus-infection-in-solid-organ-transplant-recipients-over-five-years-a-single-center-experience/. Accessed May 10, 2025.

« Back to 2020 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences